Both in Pharmaceuticals
Arrowhead Research vs TG Therapeutics
Over the past year ARWR returned +51.2% and TGTX returned +81.6%; their daily moves had a correlation of 0.24.
ARWR +51.2% TGTX +81.6%Growth of $1, one year, split-adjusted
| Metric | ARWR | TGTX |
|---|---|---|
| Price | $59.90 | $61.18 |
| Market cap | $8.46B | $9.36B |
| Today | −0.98% | +5.34% |
| 1 month | −7.5% | +14.1% |
| 6 months | −19.9% | +80.7% |
| Year to date | −9.8% | +105.2% |
| 1 year | +48.7% | +81.1% |
| Revenue growth (YoY) | +171.0% | +70.3% |
| Gross margin | 100.0% | 82.9% |
| Net margin | −258.2% | 3.2% |
| P/E (TTM) | — | 21.2× |
| Price / sales | 12.6× | 11.7× |
| Net cash | $737.9M | -$193.1M |
| Dividend yield | — | — |
| Volatility (60d) | 45.6% | 36.6% |
| Short % of float | 8.1% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).